New receptor protein targets for novel anti-cancer drugs

Grant number: 1023185 | Funding period: 2012 - 2014

Completed

Abstract

Treatment of breast and other cancers is making incremental improvements, but premature death from this disease and its recurrence in some women after a long period of remission are not adequately treated by current drugs. New work has identified a target called FPR2 that could be used to guide the development of novel drugs. The current project seeks to validate the new drug target, before resource intensive efforts are made to find suitable drugs.